Marker Therapeutics, Inc.MRKRNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-12.01T
↓ 900% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineContracting
Average
$-1.20T
Historical baseline
PeriodValueYoY Change
2025$-12.01T-110116529.0%
2024$-10.91M+33.6%
2023$-16.44M+39.0%
2022$-26.97M+1.1%
2021$-27.28M-36.2%
2020$-20.03M-9.6%
2019$-18.28M-26.3%
2018$-14.48M-71.6%
2017$-8.44M-29.6%
2016$-6.51M-